TFRC and myelodysplastic syndrome: The analysis of the antigen aberrancies in the erythroid markers CD71 CV and CD36 CV, and an abnormal percentage of CD117+ erythroid progenitor cells, have been reported to provide the best discriminating parameters between MDS and non-clonal cytopenias [20].